Adam, Aziza A. A.
Jongejan, Aldo
Moerland, Perry D.
van der Mark, Vincent A.
Oude Elferink, Ronald P.
Chamuleau, Robert A. F. M.
Hoekstra, Ruurdtje http://orcid.org/0000-0002-7325-2394
Funding for this research was provided by:
Dutch Ministry of Economic Affairs and Climate
ZonMw (114021009)
Biopredic International
Hep-Art Medical Devices B.V.
Article History
Received: 25 November 2019
Accepted: 24 February 2020
First Online: 4 March 2020
Compliance with ethical standards
:
: Robert Chamuleau is Chief Scientific Officer of the university spin-off company Hep-Art Medical Devices B.V that holds the exclusive license to the AMC-Bioartificial liver. All other authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.